“AMP is a scientifically vitally important study,” said Dr. Ken Mayer, Medical Research Director at Fenway Health and Co-Director of The Fenway Institute. “It will provide the first opportunity to evaluate whether infused antibodies can protect against HIV. If we can establish proof of concept, then next generation combination prevention approaches and vaccines can be developed.”
The AMP Study tests an experimental antibody against HIV. Participants are given an antibody to determine if it will protect against HIV infection. AMP is currently enrolling 18-50 year old, HIV uninfected men – both cisgender and transgender – who have sex with men. Participants will be compensated up to $1,800 for their time.
“The AMP Study is truly the next frontier in HIV research. If we are ever going to get to zero new HIV infections, we must create new HIV prevention tools that meet the needs of the modern generation,” noted Dwayne Steward, Manager of Community Engagement and Prevention at The Fenway Institute. “If antibody infusions are shown to prevent HIV, it could lead to revolutionary ways of keeping people from contracting this virus, and could become the next major step towards an HIV-free generation.”
We hope you’ll join us at this wonderful event for LGBTQ community leaders! Please register at www.fenwayhealth.org/ampstudy to attend.
Want to receive email updates about what’s happening at Fenway Health? Sign up here.